Pliant Therapeutics Inc (PLRX)

08:42 AM

Pliant CEO, CFO to join RBC healthcare fireside chat on May 19 - Stock Titan

08:42 AM

08:30 AM

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - GlobeNewswire

08:30 AM

May 04, 2026

PLRX SEC FilingsPliant Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 04, 2026

May 04, 2026

Pliant Therapeutics Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView

May 04, 2026

May 03, 2026

Pliant Therapeutics (NASDAQ:PLRX) Upgraded at Wall Street Zen - MarketBeat

May 03, 2026

Apr 30, 2026

Pliant Therapeutics (PLRX) Initiates Key Clinical Trial for Canc - GuruFocus

Apr 30, 2026

Apr 30, 2026

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors - Investing News Network

Apr 30, 2026

Apr 30, 2026

Pliant Therapeutics begins trial of cancer drug combination By Investing.com - Investing.com Australia

Apr 30, 2026

Apr 30, 2026

Pliant Therapeutics begins trial of cancer drug combination - Investing.com

Apr 30, 2026

Apr 30, 2026

New cancer trial starts for patients after immunotherapy stops working - Stock Titan

Apr 30, 2026

Apr 27, 2026

Pliant Therapeutics (PLRX) price target decreased by 17.95% to 2.72 - MSN

Apr 27, 2026

Apr 25, 2026

Pliant Therapeutics Inc (FRA:9PT) Stock Price & 30 Year Financial Data - GuruFocus

Apr 25, 2026

Apr 25, 2026

Wall Street Zen Downgrades Pliant Therapeutics (NASDAQ:PLRX) to Sell - MarketBeat

Apr 25, 2026

Apr 22, 2026

Pliant Therapeutics (NASDAQ: PLRX) outlines 2026 virtual meeting, board changes and pay vote - Stock Titan

Apr 22, 2026

Apr 22, 2026

[ARS] PLIANT THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 22, 2026

Apr 21, 2026

Pliant Therapeutics, Inc. (PLRX) Presents at AACR Annual Meeting 2026Slideshow (NASDAQ:PLRX) 2026-04-21 - Seeking Alpha

Apr 21, 2026

Apr 20, 2026

Primary Sclerosing Cholangitis (PSC) Market is expected to Hit - openPR.com

Apr 20, 2026

Apr 19, 2026

Pliant Therapeutics (PLRX) Reports Promising Updates on PLN-101095 Trials - GuruFocus

Apr 19, 2026

Apr 19, 2026

Pliant Therapeutics (PLRX) Reports Promising Updates on PLN-1010 - GuruFocus

Apr 19, 2026

Apr 18, 2026

Pliant Therapeutics (PLRX) Stock: Movement Analysis (Breakout Watch) 2026-04-18Elite Trading Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026

Apr 18, 2026

Pliant presents updated cancer trial data at AACR meeting By Investing.com - Investing.com South Africa

Apr 18, 2026

Apr 18, 2026

Pliant Therapeutics presents updated Phase 1 data for PLN-101095 in ICI-refractory tumors - Traders Union

Apr 18, 2026

Apr 18, 2026

Pliant presents updated cancer trial data at AACR meeting - Investing.com

Apr 18, 2026

Apr 18, 2026

Pliant Therapeutics : Final AACR 2026 PLN10195 Yap - marketscreener.com

Apr 18, 2026

Apr 18, 2026

Pliant Therapeutics Says Pln-101095 Generally Well Tolerated; Most Common Trae Was Rash, One Grade 3 Trae Observed - TradingView

Apr 18, 2026

Apr 18, 2026

Pliant Therapeutics Announces Presentation of Updated Data - GlobeNewswire

Apr 18, 2026

Apr 18, 2026

Pliant Therapeutics, Inc. 8-K SEC Filing Details for April 14, 2026 – Company Information, Registered Securities, and NASDAQ Listing - Minichart

Apr 18, 2026

Apr 17, 2026

Pliant Therapeutics Announces Board Retirements and Option Repricing - TipRanks

Apr 17, 2026

Apr 17, 2026

COO Minnie Kuo’s PLRX options repriced to $1.33 exercise price (PLRX) - Stock Titan

Apr 17, 2026

Apr 17, 2026

Form 4Statement of changes in beneficial ownership of securities - ADVFN

Apr 17, 2026

Apr 17, 2026

PLIANT THERAPEUTICS (PLRX) reprices Lily Cheung stock options at $1.33 - Stock Titan

Apr 17, 2026

Apr 17, 2026

Form 8-KCurrent report - ADVFN

Apr 17, 2026

Apr 17, 2026

Pliant Therapeutics (PLRX) CEO resets multiple option grants to $1.33 - Stock Titan

Apr 17, 2026

Apr 15, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat

Apr 15, 2026

Apr 14, 2026

Pliant Therapeutics (NASDAQ:PLRX) Shares Up 1.6%Should You Buy? - MarketBeat

Apr 14, 2026

Apr 13, 2026

If You Invested $1,000 in Pliant Therapeutics, Inc. (PLRX) - Stock Titan

Apr 13, 2026

Apr 13, 2026

Bull Run: Is Pliant Therapeutics Inc subject to activist investor interest2026 Catalysts & High Conviction Buy Zone Picks - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Inflation Data: Is Pliant Therapeutics Inc still a buy after recent gainsPortfolio Update Report & Technical Confirmation Trade Alerts - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

PLRX Technical Analysis | Trend, Signals & Chart Patterns | PLIANT THERAPEUTICS INC (NASDAQ:PLRX) - ChartMill

Apr 10, 2026

Apr 07, 2026

[EFFECT] PLIANT THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 07, 2026

Apr 06, 2026

Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Apr 06, 2026

Apr 06, 2026

Is Pliant Therapeutics (PLRX) Stock Lagging the Market | Price at $1.36, Up 0.74%Real Trader Insights - Newser

Apr 06, 2026

Apr 05, 2026

Live Pliant Therapeutics, Inc. (PLRX) Technical Analysis - Traders Union

Apr 05, 2026

Apr 05, 2026

Pliant Therapeutics (PLRX) Stock Analysis Report | Financials & Insights - Benzinga Japan

Apr 05, 2026

Apr 04, 2026

PLRX PE Ratio & Valuation, Is PLRX Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction for 2026, 2030-2040 - tradersunion.com

Apr 04, 2026

Apr 02, 2026

PLRX Stock Analysis: Pliant Therapeutics Inc. gains 3.53 percent at 1.32 dollar price point - Newser

Apr 02, 2026